Keyphrases
Plasma Protein Binding
100%
Lipophilicity
100%
Intrinsic Clearance
68%
Synthetic Cannabinoid Receptor Agonists
54%
Novel Benzodiazepines
50%
Anabolic Steroids
50%
Furanylfentanyl
50%
Prison
50%
Fentanyl Analogs
50%
Drug Interactions
50%
Metabolic Clearance
50%
Prevalence of Use
50%
Scottish
50%
Fentanyl
50%
Benzodiazepine Dependence
50%
Mode of Use
50%
Illicit Drugs
50%
Medicinal Products
50%
In Vitro Evaluation
50%
Chromatographic Hydrophobicity Index
40%
Clint
37%
Methoxyacetylfentanyl
33%
Acetylfentanyl
33%
Incubation
31%
Phosphate Buffer
25%
Human Liver Microsomes
22%
Benzodiazepines
21%
LC-MS Analysis
21%
Positive Control
21%
Donepezil
21%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
21%
Cyclopropylfentanyl
16%
Ocfentanil
16%
Hepatic Clearance
16%
Ortho
16%
μ-opioid Receptor
16%
Buffer pH
16%
Illicit Drug Markets
15%
Extended Duration
15%
Equilibrium Dialysis
15%
Smuggling
14%
Clothing
14%
Etizolam
14%
Metandienone
13%
Nandrolone
13%
Drug Clearance
13%
Cocaine
13%
Testosterone
13%
Microsomal Proteins
12%
Verapamil
12%
Pharmacology, Toxicology and Pharmaceutical Science
Plasma Protein Binding
100%
Lipophilicity
100%
Intrinsic Clearance
72%
Cannabinoid Receptor Agonist
54%
Prevalence
50%
Benzodiazepine
50%
Fentanyl Derivative
50%
Androgen
50%
Drug-Drug Interaction
50%
Tablet
50%
Duragesic
42%
Hydrophobicity
35%
Etizolam
33%
Toxic Injury
30%
Opiate
28%
Buffer
25%
Donepezil
18%
Ocfentanil
14%
Illicit Drug
14%
Drug Market
14%
Nandrolone
13%
Metandienone
13%
MDMA
13%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
11%
Verapamil
11%
Quetiapine
9%
Pooled Plasma (Human)
7%
Carfentanil
7%
Naloxone
7%
Nicardipine
7%
High Performance Liquid Chromatography
7%
Pharmacokinetics
7%
